Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 16-methylprednisone
2. Betapar
1. 1247-42-3
2. Betapar
3. Betanisona
4. Sch 4358
5. Bitanisone
6. Betapar(meprednisone)
7. Nsc 527579
8. Lepicortin-beta
9. Deltisona B
10. Deltacortene Beta
11. Sch-4358
12. Pregna-1,4-diene-3,11,20-trione, 17,21-dihydroxy-16-methyl-, (16beta)-
13. 67u96j8p35
14. Nsc-527579
15. Dsstox_cid_3260
16. Pregna-1,4-diene-3,11,20-trione, 17,21-dihydroxy-16-methyl-, (16b)-
17. Dsstox_rid_76945
18. Dsstox_gsid_23260
19. (8s,9s,10r,13s,14s,16s,17r)-17-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione
20. (8s,9s,10r,13s,14s,16s,17r)-17-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-7,8,9,10,12,13,14,15,16,17-decahydro-3h-cyclopenta[a]phenanthrene-3,11(6h)-dione
21. Meprednisona
22. Meprednisonum
23. Cas-1247-42-3
24. 16beta-methylprednisone
25. 16-beta-metilprednisone
26. 16-beta-methylprednisone
27. Meprednisonum [inn-latin]
28. Meprednisona [inn-spanish]
29. Meprednisone [usan:usp:inn]
30. Unii-67u96j8p35
31. Ncgc00182851-01
32. Einecs 214-996-1
33. Betapar (meprednisone)
34. Meprednisone (usp/inn)
35. Meprednisone [mi]
36. Meprednisone [inn]
37. Meprednisone [usan]
38. Schembl9512
39. Meprednisone [mart.]
40. 1,4-pregnadien-16-beta-methyl-17,21-diol-3,11,20-trione
41. Meprednisone [usp-rs]
42. Meprednisone [who-dd]
43. Chembl1201148
44. Dtxsid8023260
45. Chebi:135573
46. Meprednisone [orange Book]
47. Meprednisone [usp Impurity]
48. 17,21-dihydroxy-16beta-methylpregna-1,4-diene-3,11,20-trione
49. Hy-b0243
50. Zinc4216862
51. Tox21_113612
52. S1689
53. Akos025149904
54. Tox21_113612_1
55. Ccg-268328
56. Db09383
57. Pregna-1,4-diene-3,11,20-trione, 17,21-dihydroxy-16-methyl-, (16.beta.)-
58. Ncgc00182851-02
59. As-72185
60. Meprednisone 100 Microg/ml In Acetonitrile
61. D06673
62. Ab01274711-01
63. Ab01274711_02
64. 247m423
65. A805287
66. Sr-01000945264
67. J-005162
68. Q6817833
69. Sr-01000945264-1
70. Z1869763209
71. 17,21-dihydroxy-16.beta.-methylpregna-1,4-diene-3,11,20-trione
72. (16beta)-17,21-dihydroxy-16-methylpregna-1,4-diene-3,11,20-trione
73. (1r,2s,3as,3bs,9ar,9bs,11as)-1-hydroxy-1-(2-hydroxyacetyl)-2,9a,11a-trimethyl-1h,2h,3h,3ah,3bh,4h,5h,7h,9ah,9bh,10h,11h,11ah-cyclopenta[a]phenanthrene-7,10-dione
74. (1s,2r,10s,11s,13s,14r,15s)-14-hydroxy-14-(2-hydroxyacetyl)-2,13,15-trimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-diene-5,17-dione
75. (8s,9s,10r,13s,14s,16s,17r)-10,13,16-trimethyl-17-oxidanyl-17-(2-oxidanylethanoyl)-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione
76. (8s,9s,10r,13s,14s,16s,17r)-17-hydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione
| Molecular Weight | 372.5 g/mol |
|---|---|
| Molecular Formula | C22H28O5 |
| XLogP3 | 1.9 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 2 |
| Exact Mass | 372.19367399 g/mol |
| Monoisotopic Mass | 372.19367399 g/mol |
| Topological Polar Surface Area | 91.7 Ų |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 795 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 7 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
H - Systemic hormonal preparations, excl. sex hormones and insulins
H02 - Corticosteroids for systemic use
H02A - Corticosteroids for systemic use, plain
H02AB - Glucocorticoids
H02AB15 - Meprednisone
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Methylprednisone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Methylprednisone, including repackagers and relabelers. The FDA regulates Methylprednisone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Methylprednisone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Methylprednisone manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Methylprednisone supplier is an individual or a company that provides Methylprednisone active pharmaceutical ingredient (API) or Methylprednisone finished formulations upon request. The Methylprednisone suppliers may include Methylprednisone API manufacturers, exporters, distributors and traders.
click here to find a list of Methylprednisone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Methylprednisone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Methylprednisone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Methylprednisone GMP manufacturer or Methylprednisone GMP API supplier for your needs.
A Methylprednisone CoA (Certificate of Analysis) is a formal document that attests to Methylprednisone's compliance with Methylprednisone specifications and serves as a tool for batch-level quality control.
Methylprednisone CoA mostly includes findings from lab analyses of a specific batch. For each Methylprednisone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Methylprednisone may be tested according to a variety of international standards, such as European Pharmacopoeia (Methylprednisone EP), Methylprednisone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Methylprednisone USP).
LOOKING FOR A SUPPLIER?
